BGLAP and osteoporosis: There was no difference in BMD but the percent of undercarboxylated osteocalcin was reduced in those receiving additional vitamin K. In women with no osteoporosis, groups were supplemented with either a placebo, calcium and vitamin D, vitamin K or calcium (1000 mg), and vitamin D (400 IU) with vitamin K (200 μg) [38].